Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Alliance A031501: Phase III randomized adjuvant study of MK-3475 (pembrolizumab) in muscle-invasive and locally advanced urothelial carcinoma (MIBC) (AMBASSADOR) versus observation. Apolo, A. B., Rosenberg, J. E., Kim, W. Y., Chen, R. C., Sonpavde, G., Srinivas, S., Mortazavi, A., Watt, C., Mallek, M., Graap, K., Diaz, C., Odegaard, M., Ballman, K. V., Morris, M. J. AMER SOC CLINICAL ONCOLOGY. 2019
View details for DOI 10.1200/JCO.2019.37.7_suppl.TPS504
View details for Web of Science ID 000489108800037